International Clinical Trial: Perioperative risk stratification based on respiratory muscle sarcopenia in lung cancer patients

Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600131449) titled 'Perioperative risk stratification based on respiratory muscle sarcopenia in lung cancer patients' on Sept. 2.

Study Type: Observational study

Study Design: Cohort study

Primary Sponsor: Fujian Medical University Union Hospital

Condition: Lung cancer

Intervention: Respiratory muscle sarcopenia group:None Pre-respiratory muscle sarcopenia group:None

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-11-01

Target Sample Size: Respiratory muscle sarcopenia group:147;Pre-respiratory muscle sarcopenia group:147;Normal group:146;

Countries of Recruitment: China

To know more, v...